Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Insider-Favored Growth Stocks To Consider In February 2025

In This Article:

As global markets navigate a complex landscape marked by fluctuating interest rates and technological disruptions, investors are keeping a close eye on sectors that show resilience amid volatility. With the Federal Reserve holding rates steady and AI competition intensifying, identifying growth companies with high insider ownership can offer unique insights into potential opportunities. In this environment, stocks where insiders have significant stakes may signal confidence in the company's long-term prospects, aligning well with current market dynamics.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Seojin SystemLtd (KOSDAQ:A178320)

32.1%

39.9%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.2%

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

26.2%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Laopu Gold (SEHK:6181)

36.4%

36.9%

Medley (TSE:4480)

34.1%

27.3%

Plenti Group (ASX:PLT)

12.7%

120.1%

Fine M-TecLTD (KOSDAQ:A441270)

17.1%

135%

HANA Micron (KOSDAQ:A067310)

18.3%

119.4%

Brightstar Resources (ASX:BTR)

16.2%

86%

Click here to see the full list of 1471 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Samyang Foods

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Samyang Foods Co., Ltd., along with its subsidiaries, operates in the food industry both in South Korea and internationally, with a market cap of ₩6.03 trillion.

Operations: Samyang Foods generates revenue from its food business operations both domestically and internationally.

Insider Ownership: 11.6%

Samyang Foods is experiencing significant growth, with earnings expected to increase by 26.58% annually and recent profits up 133.8%. While its revenue growth forecast of 19.8% per year trails the 20% benchmark, it surpasses the Korean market average of 8.9%. Trading at a substantial discount to its estimated fair value, Samyang Foods benefits from high insider ownership, aligning management interests with shareholders despite no recent insider trading activity reported.

KOSE:A003230 Earnings and Revenue Growth as at Feb 2025
KOSE:A003230 Earnings and Revenue Growth as at Feb 2025

Alibaba Health Information Technology

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Alibaba Health Information Technology Limited operates in pharmaceutical direct sales, pharmaceutical e-commerce platforms, and healthcare and digital services in Mainland China and Hong Kong, with a market cap of HK$60.47 billion.